Alternaturals (OTCPK:ANAS) - Stock Price, News & Analysis

ANAS Stock Overview

Manufactures and distributes supplements and all-natural remedies that are alternatives to prescription drugs. More details

ANAS fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Does not have a meaningful market cap ($573K)

Shares are highly illiquid

Alternaturals, Inc. Competitors

AmeriCann

OTCPK:ACAN

US$465.9k

Kid Castle Educational

OTCPK:KDCE

US$357.2k

SciSparc

NasdaqCM:SPRC

US$768.3k

TFF Pharmaceuticals

NasdaqCM:TFFP

US$1.5m

Price History & Performance

Summary of all time highs, changes and price drops for Alternaturals
Historical stock prices
Current Share Price	US$0.0055
52 Week High	US$0.0085
52 Week Low	US$0.0035
Beta	0
11 Month Change	-21.43%
3 Month Change	0%
1 Year Change	-18.52%
33 Year Change	-84.29%
5 Year Change	-45.00%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	ANAS	US Pharmaceuticals	US Market
7D	0%	2.6%	0.5%
1Y	-18.5%	13.1%	30.7%

Return vs Industry: ANAS underperformed the US Pharmaceuticals industry which returned 13.1% over the past year.

Return vs Market: ANAS underperformed the US Market which returned 30.7% over the past year.

Price Volatility

Is ANAS's price volatile compared to industry and market?
ANAS volatility
ANAS Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.9%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.1%

Stable Share Price: ANAS's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine ANAS's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1995	n/a	n/a	n/a

Alternaturals, Inc. manufactures and distributes supplements and all-natural remedies that are alternatives to prescription drugs. Its products include Focamine, an all-natural focus, attention, and concentration promoter for people suffering from ADHD; and Sombium, an alternative sleep aid. The company was formerly known as Zhong Nong Yuan Fang Holdings, Inc. and changed its name to Alternaturals, Inc. in March 2022.

Alternaturals, Inc. Fundamentals Summary

How do Alternaturals's earnings and revenue compare to its market cap?
ANAS fundamental statistics
Market cap	US$573.36k
Earnings (TTM)	-US$381.30k
Revenue (TTM)	n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Is ANAS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ANAS income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$381.30k
Earnings	-US$381.30k

Last Reported Earnings

Sep 30, 2001

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did ANAS perform over the long term?

See historical performance and comparison